Who to call at BioLineRx Ltd, and when
Fundz watches for the moments BioLineRx Ltd starts buying, and tells you who to reach.
- An alert the day BioLineRx Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioLineRx Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioLineRx Ltd. With Fundz connected, it knows.
BioLineRx Enters into $5.6 Million Agreement for Royalty Monetization with Soleus Capital to Fund GLIX1 Development.
Contract Type
agreement
Description
BioLineRx has entered into an agreement with Soleus Capital for the sale of its future royalty payments from APHEXDA for a one-time payment of $5.6 million. The funds will support the ongoing Phase 1/2a clinical trial of GLIX1, while the company retains rights to future milestone payments.
Quick answer
BioLineRx Enters into $5.6 Million Agreement for Royalty Monetization with Soleus Capital to Fund GLIX1 Development. (November 18, 2026). BioLineRx Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- What agreement did BioLineRx Ltd announce on November 18, 2026?
- BioLineRx has entered into an agreement with Soleus Capital for the sale of its future royalty payments from APHEXDA for a one-time payment of $5.6 million. The funds will support the ongoing Phase 1/2a clinical trial of GLIX1, while the company retains rights to future milestone payments.
- What does BioLineRx Ltd do?
- BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases.
- Where is BioLineRx Ltd based?
- BioLineRx Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- Which similar companies announced agreements around the same time?
- AbbVie Inc. (November 3, 2026), Aarvik Therapeutics (November 3, 2026), AstraZeneca Pharma India (November 17, 2026) and Kernal Biologics (November 17, 2026) also announced agreements within 45 days of BioLineRx Ltd.
Source: Fundz verified event record.
Other recent agreements in Healthcare and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India. (November 3, 2026)
- AstraZeneca Pharma India Forms Partnership with Strand Life Sciences for Healthcare Collaboration. (November 17, 2026)
- Kernal Bio Establishes Partnership with IFLI to Advance KR-402 for Follicular Lymphoma Treatment. (November 17, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
Related People
BioLineRx Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.